EVALUATION OF NO EVIDENCE OF PROGRESSION OR ACTIVE DISEASE (NEPAD) IN PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS IN THE ORATORIO TRIAL

被引:0
|
作者
Wolinsky, Jerry [1 ]
Montalban, Xavier [2 ]
Kappos, Ludwig [3 ]
Hauser, Stephen [4 ]
Giovannoni, Gavin [5 ]
de Seze, Jerome [6 ]
Bar-Or, Amit [7 ]
Masterman, Donna [8 ]
Bernasconi, Corrado [9 ]
Wei, Wei [9 ]
Garren, Hideki [9 ]
Chin, Peter [8 ]
Belachew, Shibeshih [9 ]
Arnold, Doug L. [10 ,11 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA
[2] Vall dHebron Univ Hosp, Barcelona, Spain
[3] Univ Hosp, Basel, Switzerland
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Queen Mary Univ London, London, England
[6] Univ Hosp Strasbourg, Strasbourg, France
[7] Univ Penn, Philadelphia, PA 19104 USA
[8] Genentech Inc, San Francisco, CA 94080 USA
[9] F Hoffmann La Roche Ltd, Basel, Switzerland
[10] McGill Univ, Montreal, PQ, Canada
[11] NeuroRx Res, Montreal, PQ, Canada
来源
关键词
D O I
10.1136/jnnp-2017-316074.83
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
83
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis
    Fissolo, Nicolas
    Benkert, Pascal
    Sastre-Garriga, Jaume
    Mongay-Ochoa, Neus
    Vilaseca-Jolonch, Andreu
    Llufriu, Sara
    Blanco, Yolanda
    Hegen, Harald
    Berek, Klaus
    Perez-Miralles, Francisco
    Rejdak, Konrad
    Villar, Luisa M.
    Monreal, Enric
    Alvarez-Lafuente, Roberto
    Soylu, Onder K.
    Abdelhak, Ahmed
    Bachhuber, Franziska
    Tumani, Hayrettin
    Martinez-Yelamos, Sergio
    Sanchez-Lopez, Antonio J.
    Garcia-Merino, Antonio
    Gutierrez, Lucia
    Castillo-Trivino, Tamara
    Lycke, Jan
    Rosenstein, Igal
    Furlan, Roberto
    Filippi, Massimo
    Tellez, Nieves
    Ramio-Torrenta, Lluis
    Lunemann, Jan D.
    Wiendl, Heinz
    Eichau, Sara
    Khalil, Michael
    Kuhle, Jens
    Montalban, Xavier
    Comabella, Manuel
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (05): : 410 - 418
  • [42] Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis
    Abdel-Aziz, Khaled
    Schneider, Torben
    Solanky, Bhavana S.
    Yiannakas, Marios C.
    Altmann, Dan R.
    Wheeler-Kingshott, Claudia A. M.
    Peters, Amy L.
    Day, Brian L.
    Thompson, Alan J.
    Ciccarelli, Olga
    BRAIN, 2015, 138 : 1568 - 1582
  • [43] Does the DRB1*1501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis
    Ferreira Vasconcelos, Claudia Cristina
    Fernandez, Oscar
    Leyva, Laura
    Santos Thuler, Luiz Claudio
    Papais Alvarenga, Regina Maria
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 214 (1-2) : 101 - 103
  • [44] Anti-inflammatory disease modifying treatment and disability progression in primary progressive multiple sclerosis
    Lorscheider, J.
    Kuhle, J.
    Izquierdo, G.
    Lugaresi, A.
    Havrdova, E.
    Horakova, D.
    Hupperts, R.
    Duquette, P.
    Girard, M.
    Prat, A.
    Grand'Maison, F.
    Grammond, P.
    Sola, P.
    Ferraro, D.
    Trojano, M.
    Ramo-Tello, C.
    Lechner-Scott, J.
    Pucci, E.
    Slee, M.
    Van Pesch, V.
    Van der Walt, A.
    Butzkueven, H.
    Kappos, L.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 398 - 399
  • [45] A Multiparametric Evaluation of Regional Brain Damage in Patients With Primary Progressive Multiple Sclerosis
    Ceccarelli, Antonia
    Rocca, Maria A.
    Valsasina, Paola
    Rodegher, Mariaemma
    Pagani, Elisabetta
    Falini, Andrea
    Comi, Giancarlo
    Filippi, Massimo
    HUMAN BRAIN MAPPING, 2009, 30 (09) : 3009 - 3019
  • [46] Treatment Patterns of Patients with Active and Nonactive Primary Progressive Multiple Sclerosis in the United States
    Thirumalai, D.
    Watson, C.
    Sadetsky, N.
    Barlev, A.
    Jones, E.
    Bogdanovich, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 177 - 178
  • [47] Active inflammation in primary progressive multiple sclerosis: a systematic review
    Blok, K.
    Smolders, J.
    Tebayna, N.
    Van Rosmalen, J.
    Wokke, B.
    De Beukelaar, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 927 - 927
  • [48] Brain Volume as a Predictor of Disability in Primary Progressive Multiple Sclerosis: Evidence from the INFORMS Trial
    Wolinsky, Jerry
    Haring, Dieter
    Sormani, Maria Pia
    Lublin, Fred
    Miller, David
    Freedman, Mark
    Cree, Bruce
    Weiner, Howard
    Lubetzki, Catherine
    Hartung, Hans-Peter
    Montalban, Xavier
    Uitdehaag, Bernard
    Merschhemke, Martin
    Li, Bingbing
    Pulzki, Norman
    Kappos, Ludwig
    NEUROLOGY, 2016, 86
  • [49] Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability
    Ana Paula Kallaur
    Sayonara Rangel Oliveira
    Andréa Name Colado Simão
    Daniela Frizon Alfieri
    Tamires Flauzino
    Josiane Lopes
    Wildea Lice de Carvalho Jennings Pereira
    Caio de Meleck Proença
    Sueli Donizete Borelli
    Damacio Ramón Kaimen-Maciel
    Michael Maes
    Edna Maria Vissoci Reiche
    Molecular Neurobiology, 2017, 54 : 2950 - 2960
  • [50] Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability
    Kallaur, Ana Paula
    Oliveira, Sayonara Rangel
    Colado Simao, Andrea Name
    Alfieri, Daniela Frizon
    Flauzino, Tamires
    Lopes, Josiane
    de Carvalho Jennings Pereira, Wildea Lice
    Proenca, Caio de Meleck
    Borelli, Sueli Donizete
    Kaimen-Maciel, Damacio Ramon
    Maes, Michael
    Vissoci Reiche, Edna Maria
    MOLECULAR NEUROBIOLOGY, 2017, 54 (04) : 2950 - 2960